Károly Tihanyi

Title: Károly Tihanyi: Innovator in Pharmaceutical Chemistry

Introduction

Károly Tihanyi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target central nervous system disorders. With a total of 3 patents to his name, Tihanyi's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Tihanyi's latest patents include innovative compounds such as 8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, which serve as AMPA/kainate receptor inhibitors. This patent discloses a novel compound of formula I and its pharmaceutically acceptable quaternary ammonium salts. The compounds possess unique competitive AMPA/kainate antagonist properties, making them useful in treating diseases where inhibition of these receptors may have a favorable effect. Another significant patent involves piperazinylalkylthiopyrimidine derivatives, which are also aimed at treating central nervous system disorders, particularly anxiety.

Career Highlights

Throughout his career, Tihanyi has worked with various companies, including Egis Gyogyszergyar Rt. His expertise in pharmaceutical chemistry has allowed him to develop compounds that address critical health issues. His innovative approach and dedication to research have positioned him as a key figure in his field.

Collaborations

Tihanyi has collaborated with notable colleagues such as Gyula Simig and András Egyed. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Károly Tihanyi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of central nervous system disorders.